Katherine L Pogue-Geile
3PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jun 27, 2025
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy.Dong Hu, Xiaoshuang Lyu, Zheqi Li
|Feb 02, 2023
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.Carsten Denkert, Chiara Lambertini, Peter A Fasching
|Aug 18, 2018
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.Rekha Pal, Ning Wei, Nan Song
Pageof 1
Frequent Collaborators
2 joint publications
Norman Wolmark
2 joint publications
Peter C Lucas
1 joint publications
Soonmyung Paik
1 joint publications
Carsten Denkert
1 joint publications
Chiara Lambertini
1 joint publications
Peter A Fasching
1 joint publications
Max S Mano
1 joint publications
Michael Untch
1 joint publications
Chiun-Sheng Huang
1 joint publications
Sibylle Loibl
